We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ilika Plc | LSE:IKA | London | Ordinary Share | GB00B608Z994 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -1.79% | 27.50 | 27.00 | 28.00 | 28.00 | 27.50 | 28.00 | 87,732 | 14:09:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 702k | -7.3M | -0.0459 | -5.99 | 43.72M |
TIDMIKA
RNS Number : 3157Z
Ilika plc
14 March 2017
Ilika plc
("Ilika" or the "Company")
Ilika and Galvani Bioelectronics enter into collaboration in Bioelectronics Project
Ilika (AIM: IKA), a pioneer in materials innovation and solid-state battery technology, announces a two-year collaborative project with Galvani Bioelectronics to develop a solid state battery for miniature medical implants. Ilika's Stereax(TM) batteries have a high power density, a long battery life and they can be produced in miniature form, making them particularly suitable for these micro-devices.
This collaboration aims to deliver key components of bioelectronic devices, which have the potential to provide treatments for serious health conditions, through the body's own nervous system.
The GBP1.0 million development project is supported by funding of GBP0.7 million, which Ilika will receive from Innovate UK and the Medical Research Council.
Commenting on this grant award, Graeme Purdy, Ilika CEO, said: "This partnership with Galvani Bioelectronics, using Ilika's lithium-ion Stereax battery technology, may provide the potential to treat diseases that have so far been difficult to manage. Collaborations like this are critical to the delivery of advances in the field of solid state battery development."
For more information, contact:
Ilika plc www.ilika.com Graeme Purdy, Chief Tel: 023 8011 1400 Executive Steve Boydell, Finance Director Numis Securities Limited Tel: 020 7260 1000 Oliver Cardigan/ Paul Gillam / James Black Walbrook PR Ltd Tel: 020 7933 8780 / ilika@walbrookpr.com Paul Cornelius Mob: 07866 384 707 Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCJJMFTMBMBBFR
(END) Dow Jones Newswires
March 14, 2017 03:00 ET (07:00 GMT)
1 Year Ilika Chart |
1 Month Ilika Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions